Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 in Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions

Solid Tumor

Interventions

DRUG

ombrabulin (AVE8062)

"Pharmaceutical form: injection solution~Route of administration: intravenous infusion"

Trial Locations (2)

Sanofi-Aventis Investigational Site Number 392002, Osaka Sayama-Shi

Sanofi-Aventis Investigational Site Number 392001, Sunto-Gun